GlassScriptPhysician profile
Stephen Dean Rose
NPI 1639160476
$1,716.03
in general payments reported to CMS, 2019-2025
16 companies · $141 in 2025
The $141 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $323 · 2020: $829 · 2022: $170 · 2024: $253 · 2025: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $394.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $542.10 | 2020 | |
| Medinc of Texas | $242.49 | 2020 | |
| Stryker Corporation | $167.19 | 2019-2022 | |
| Abbott Laboratories | $146.37 | 2024 | Proclaim |
| Ossur Americas, INC. | $141.07 | 2025 | |
| Radius Health, INC. | $122.91 | 2019 | |
| Orthofix Medical, INC. | $92.97 | 2024 | Physio-Stim |
| Orthogenrx INC. | $60.42 | 2019 | |
| Bioventus LLC | $47.33 | 2019-2022 | |
| Axogen | $43.76 | 2019 | |
| Akcea Therapeutics, INC. | $26.42 | 2020 | |
| Depuy Synthes Sales INC. | $21.53 | 2019 | |
| Pacira Therapeutics, INC. | $18.24 | 2020 | |
| Endo Pharmaceuticals INC. | $17.08 | 2019 | |
| Anika Therapeutics, INC. | $13.70 | 2024 | Tactoset, Ovomotion |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $12.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Rose listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.